FdaApplication
NDA 218230
Identifiers
- fda_app_no: NDA218230
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE LLC |
| application_type | NDA |
| approval_date | 2025-03-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BLUJEPA | GEPOTIDACIN MESYLATE | EQ 750MG BASE | TABLET;ORAL |
1 product